Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

OBJECTIVES: To evaluate the impact of discontinuation of adalimumab (ADA) for 1 year in Japanese patients with early rheumatoid arthritis (RA). METHODS: This 52-week postmarketing study, HOPEFUL-2, enrolled patients who had completed HOPEFUL-1 for early RA, in which patients received either ADA + me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RMD Open
Hauptverfasser: Tanaka, Yoshiya, Yamanaka, Hisashi, Ishiguro, Naoki, Miyasaka, Nobuyuki, Kawana, Katsuyoshi, Hiramatsu, Katsutoshi, Takeuchi, Tsutomu
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2016
Schlagworte:
Rheumatoid Arthritis
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762209/
https://ncbi.nlm.nih.gov/pubmed/26925252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000189
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge